Personalized medicine means the “Four Rights” – the right medicine for the right patient, in the right dose at the right time. We’ve made some significant strides forward via (among other things) molecular diagnostics – but we’ve only scratched the surface.
Consider two recent studies on how we’re diagnosing and treating depression.
According to the Wall Street Journal, “More Americans are being prescribed multiple psychiatric medications for use at the same time, but most people diagnosed with recent depression don't get adequate treatment, according to two independent studies published Monday.”
Advancing the tools and techniques of personalized medicine is real healthcare reform. And there’s no better place to start than with the FDA’s Critical Path Program and its Reagan Udall Foundation.
To paraphrase – we have promises to keep. And miles to go before we sleep.
